X-111247922-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_014289.4(CAPN6):āc.1555C>Gā(p.Gln519Glu) variant causes a missense change. The variant allele was found at a frequency of 0.0000968 in 1,208,463 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 28 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000045 ( 0 hom., 1 hem., cov: 23)
Exomes š: 0.00010 ( 0 hom. 27 hem. )
Consequence
CAPN6
NM_014289.4 missense
NM_014289.4 missense
Scores
2
4
11
Clinical Significance
Conservation
PhyloP100: 5.91
Genes affected
CAPN6 (HGNC:1483): (calpain 6) Calpains are ubiquitous, well-conserved family of calcium-dependent, cysteine proteases. The calpain proteins are heterodimers consisting of an invariant small subunit and variable large subunits. The large subunit possesses a cysteine protease domain, and both subunits possess calcium-binding domains. Calpains have been implicated in neurodegenerative processes, as their activation can be triggered by calcium influx and oxidative stress. The protein encoded by this gene is highly expressed in the placenta. Its C-terminal region lacks any homology to the calmodulin-like domain of other calpains. The protein lacks critical active site residues and thus is suggested to be proteolytically inactive. The protein may play a role in tumor formation by inhibiting apoptosis and promoting angiogenesis. [provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.32129008).
BS2
High Hemizygotes in GnomAdExome4 at 27 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CAPN6 | NM_014289.4 | c.1555C>G | p.Gln519Glu | missense_variant | 11/13 | ENST00000324068.2 | NP_055104.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CAPN6 | ENST00000324068.2 | c.1555C>G | p.Gln519Glu | missense_variant | 11/13 | 1 | NM_014289.4 | ENSP00000317214.1 |
Frequencies
GnomAD3 genomes AF: 0.0000445 AC: 5AN: 112252Hom.: 0 Cov.: 23 AF XY: 0.0000291 AC XY: 1AN XY: 34412
GnomAD3 genomes
AF:
AC:
5
AN:
112252
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
34412
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000437 AC: 8AN: 183155Hom.: 0 AF XY: 0.0000591 AC XY: 4AN XY: 67671
GnomAD3 exomes
AF:
AC:
8
AN:
183155
Hom.:
AF XY:
AC XY:
4
AN XY:
67671
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000102 AC: 112AN: 1096211Hom.: 0 Cov.: 29 AF XY: 0.0000747 AC XY: 27AN XY: 361597
GnomAD4 exome
AF:
AC:
112
AN:
1096211
Hom.:
Cov.:
29
AF XY:
AC XY:
27
AN XY:
361597
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000445 AC: 5AN: 112252Hom.: 0 Cov.: 23 AF XY: 0.0000291 AC XY: 1AN XY: 34412
GnomAD4 genome
AF:
AC:
5
AN:
112252
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
34412
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
3
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2022 | The c.1555C>G (p.Q519E) alteration is located in exon 11 (coding exon 10) of the CAPN6 gene. This alteration results from a C to G substitution at nucleotide position 1555, causing the glutamine (Q) at amino acid position 519 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T
M_CAP
Pathogenic
D
MetaRNN
Benign
T
MetaSVM
Uncertain
T
MutationAssessor
Benign
M
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Benign
T
Polyphen
D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at